HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mihaela Ginj Selected Research

Terbium-161

1/2022Combination of terbium-161 with somatostatin receptor antagonists-a potential paradigm shift for the treatment of neuroendocrine neoplasms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mihaela Ginj Research Topics

Disease

10Neoplasms (Cancer)
01/2022 - 01/2004
1Hypoxia (Hypoxemia)
01/2016
1Colorectal Neoplasms (Colorectal Cancer)
06/2010
1Pituitary ACTH Hypersecretion
02/2010
1Acromegaly
02/2010
1Carcinoid Tumor (Carcinoid)
02/2010
1Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2006

Drug/Important Bio-Agent (IBA)

7Somatostatin Receptors (Somatostatin Receptor)IBA
01/2022 - 02/2005
6Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2022 - 01/2004
51,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2022 - 02/2005
3Peptides (Polypeptides)IBA
01/2022 - 01/2004
2Octreotide (Sandostatin)FDA LinkGeneric
02/2010 - 10/2006
1TerbiumIBA
01/2022
1Edotreotide (SMT 487)IBA
01/2022
1Terbium-161IBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2016
1Pharmaceutical PreparationsIBA
06/2010
1polyethylene glycol 2000IBA
06/2010
11,2-distearoylphosphatidylethanolamine (DSPE)IBA
06/2010
1Liposomes (Liposome)IBA
06/2010
1pasireotideIBA
02/2010
1LigandsIBA
04/2008
1SugarsIBA
01/2007
1Peptide Receptors (Peptide Receptor)IBA
10/2006
1AcidsIBA
10/2006
1Radioisotopes (Radionuclides)IBA
12/2005
1Biological ProductsIBA
12/2005
1yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acidIBA
02/2005

Therapy/Procedure

4Radiotherapy
01/2007 - 01/2004
2Therapeutics
12/2005 - 01/2004